Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
The DOI matches its Crossref record; 23 of the 26 references it cites were found in a registry or an index.
Abstract
We analyzed data from the National Nosocomial Infections Surveillance (NNIS) System from 1986-2003 to determine the epidemiology of gram-negative bacilli in intensive care units (ICUs) for the most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI). We analyzed >410,000 bacterial isolates associated with hospital-acquired infections in ICUs during 1986-2003. In 2003, gram-negative bacilli were associated with 23.8% of BSIs, 65.2% of pneumonia episodes, 33.8% of SSIs, and 71.1% of UTIs. The percentage of BSIs associated with gram-negative bacilli decreased from 33.2% in 1986 to 23.8% in 2003. The percentage of SSIs associated with gram-negative bacilli decreased from 56.5% in 1986 to 33.8% in 2003. The percentages pneumonia episodes and UTIs associated with gram-negative bacilli remained constant during the study period. The proportion of ICU pneumonia episodes associated with Acinetobacter species increased from 4% in 1986 to 7.0% in 2003 (P<.001, by the Cochran-Armitage chi2 test for trend). Significant increases in resistance rates were uniformly seen for selected antimicrobial-pathogen combinations. Gram-negative bacilli are commonly associated with hospital-acquired infections in ICUs. The proportion of Acinetobacter species associated with ICU pneumonia increased from 4% in 1986 to 7.0% in 2003.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a group, these organisms are the most common etiology of nosocomial infections, including most cases of hospital-acquired pneumonia, ventilator-associated pneumonia and healthcare-associated pneumonia, and they are important causes of morbidity and death in hospitalized patients (1).”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [1]
Citations
Cites
Vincent, J.-L. (1995) · JAMA · doi:10.1001/jama.1995.03530080055041 · Cited by 1,632 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
Hospital Epidemiology and Infection Control
Mayhall, C. G. (2011) · Cited by 1,179
National nosocomial infections surveillance system (NNIS): Description of surveillance methods
Emori, T. G., Culver, D. H., Horan, T. C., Jarvis, W. R., White, J. W., Olson, D. R., Banerjee, S., Edwards, J. R., Martone, W. J., Gaynes, R. P., et al. (1991) · American Journal of Infection Control · doi:10.1016/0196-6553(91)90157-8 · Cited by 832
Self-citationSurveillance nosokomialer Infektionen
Gastmeier (2004) · Therapeutische Umschau · doi:10.1024/0040-5930.61.3.204 · Cited by 509
Epidemiology and control of nosocomial infections in adult intensive care units
Weinstein, R. A. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90366-6 · Cited by 300 · cited 1×
“the 4 most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI) [1].”
BackgroundSelf-citationMultidrug-Resistant Acinetobacter baumannii
Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y., & Carmeli, Y. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040001 · Cited by 285 · cited 1×
“Acinetobacter organisms are intrinsically resistant to many antimicrobials and can acquire resistance to others [7].”
BackgroundHOSPITAL ACQUIRED INFECTIONS: KNOWLEDGE ABOUT IT AND ITS PREVENTION
QAYYUM, S., WAQAS, B., & SATTAR, A. (2010) · The Professional Medical Journal · doi:10.29309/tpmj/2010.17.02.2211 · Cited by 256
MAGNITUDE AND PREVENTION OF NOSOCOMIAL INFECTIONS IN THE INTENSIVE CARE UNIT
Fridkin, S. K., Welbel, S. F., & Weinstein, R. A. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70366-4 · Cited by 225 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
BackgroundSelf-citationStreit, J. M., Jones, R. N., Sader, H. S., & Fritsche, T. R. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.019 · Cited by 191
Syncope and orthostatic hypotension
Atkins, D., Hanusa, B., Sefcik, T., & Kapoor, W. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90012-m · Cited by 172
Research works printed but not linked: 2
- 1991, The American journal of medicine, 91, 86
- Richards, 2003, Annals of surgery, 237, 358, 10.1097/00000658-200303000-00009 · doi:10.1097/00000658-200303000-00009
Cited by
Items 701–800 of 1,000
van der Sluijs, A. V. E., Oosterheert, J. J., Ekkelenkamp, M. B., Hoepelman, I. M., & Peters, E. J. G. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1401-0 · Cited by 19
“Based on these findings, the guidelines regarding the prevention of intravascular catheter-related infections of Table 1 Characteristics of the 213 cases with intravascular catheter tips colonized with Gram-negative micro-organisms in 181 patients No subsequent GNB (n=173) Subsequent GNB (n=40) p-value OR of differenc…”
BackgroundInfluentialVasudevan, A., Mukhopadhyay, A., Goh, E. Y.-Y., Li, J., & Tambyah, P. A. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2012.12.003 · Cited by 17
Treatment of Pseudomonas aeruginosa infection in critically ill patients
Grossi, P., & Gasperina, D. D. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.4.639 · Cited by 20
Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients
Cairo, J., Hachem, R. Y., Rangaraj, G., Granwehr, B. P., & Raad, I. I. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03504.x · Cited by 19
Antimicrobial polyurethanes for intravascular medical devices
Francolini, I., & Piozzi, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100614-6.00012-3 · Cited by 19
Aly, S. A., Tawfeek, R. A., & Mohamed, I. (2016) · Al-Azhar Assiut Medical Journal · doi:10.4103/1687-1693.192652 · Cited by 17
Microorganisms present on peripheral intravenous needleless connectors in the clinical environment
Slater, K., Cooke, M. L., Whitby, M., Fullerton, F., Douglas, J., Hay, J., & Rickard, C. M. (2017) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.02.008 · Cited by 17
Edgar, R. J., Hampton, G. E., Garcia, G. P. C., Maher, M. J., Perugini, M. A., Ackerley, D. F., & Lamont, I. L. (2017) · Molecular Microbiology · doi:10.1111/mmi.13855 · Cited by 20
“P. aeruginosa causes a wide range of both chronic and acute infections in patients with a variety of predisposing conditions (Gaynes and Edwards, 2005; Driscoll et al., 2007).”
BackgroundBrewer, L. K., Jones, J. W., Blackwood, C. B., Barbier, M., Oglesby, A. G., & Kane, M. A. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02374-0 · Cited by 17
Liu, L., Liu, B., & Li, W. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s260525 · Cited by 17
Eguchi, K., Kanazawa, K., Shimizudani, T., Kanemitsu, K., & Kaku, M. (2010) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-009-0001-8 · Cited by 17
“aeruginosa infections has revealed trends of increasing antimicrobial resistance, including carbapenem resistance and multidrug resistance [3–6].”
BackgroundImpact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia
Tam, V. H., Chang, K., Schilling, A. N., LaRocco, M., Genty, L. O., & Garey, K. W. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.11.007 · Cited by 17
“aeruginosawas the leading cause of nosocomial Gram-negative pneumonia and the 3rd most common cause of Gram-negative nosocomial bacteremia in 2003 (Gaynes and Edwards, 2005).”
BackgroundImpact of wound microbiology on limb preservation in patients with diabetic foot infection
Hung, S., Chiu, C., Huang, C., Lin, C., Yeh, J., Yang, H., & Huang, Y. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13649 · Cited by 16
Aguiar-Alves, F., Le, H. N., Tran, V. G., Gras, E., Vu, T. T. T., Dong, O. X., Quetz, J. D. S., Cheng, L., Yu, L., Sellman, B. R., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02022-21 · Cited by 16
Onita, T., Ikawa, K., Ishihara, N., Tamaki, H., Yano, T., Naora, K., & Morikawa, N. (2023) · Antibiotics · doi:10.3390/antibiotics12020303 · Cited by 16
“Meanwhile, Acinetobacter baumannii is a globally important pathogen that causes infectious diseases such as ventilator‐related pneumonia [8,9].”
BackgroundAlves, J. V., Westling, L., Peters, E. C., Harris, J. L., & Trauger, J. W. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.05.041 · Cited by 16
Resistance Profiles in Surgical-Site Infection
Lenz, A. M., Fairweather, M., & Cheadle, W. G. (2008) · Future Microbiology · doi:10.2217/17460913.3.4.453 · Cited by 18
“reviewed NNIS data for epidemiologic changes in commonly isolated pathogens associated with different infections between 1986 and 2003 [17].”
MethodANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
Akova, M. (2016) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2017.002 · Cited by 19
Liu, X., Yang, T., Sun, T., & Shao, K. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6045 · Cited by 16
Rahim, K., Saleha, S., Basit, A., Zhu, X., Ahmed, I., Huo, L., Zhang, P., Usman, B., Munir, S., & Franco, O. L. (2017) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.57564 · Cited by 17
Multidrug ResistantAcinetobacter baumanii: A 15-Year Trend Analysis
Russell, D. L., Uslan, D. Z., Rubin, Z., Grogan, T., & Martin, E. M. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2018.52 · Cited by 16
Structure-based Druggability Assessment of Anti-virulence Targets from Pseudomonas aeruginosa
Froes, T. Q., Baldini, R. L., Vajda, S., & Castilho, M. S. (2019) · Current Protein and Peptide Science · doi:10.2174/1389203720666190417120758 · Cited by 16
Yang, X., Lai, Y.-R., Li, C., Yang, J., Jia, M., & Sheng, J. (2020) · Brazilian Journal of Biology · doi:10.1590/1519-6984.226309 · Cited by 16
Vo-Pham-Minh, T., Duong-Thi-Thanh, V., Nguyen, T. N., Phan-Tran-Xuan, Q., Phan, H., Bui-Anh, T., Duong, P. T., & Duong‐Quy, S. (2021) · Pulmonary Therapy · doi:10.1007/s41030-021-00175-4 · Cited by 16
Walkty, A. J., DeCorby, M. R., Nichol, K. A., Mulvey, M. R., Hoban, D. J., & Zhanel, G. G. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.01.009 · Cited by 16
Lin, C.-H., Su, S.-C., Ho, K.-H., Hsu, Y., & Lee, K. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.03.004 · Cited by 16
Cooper, T. W., Pass, S. E., Brouse, S. D., & Hall, R. G. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p187 · Cited by 18
Nosocomial Infections Caused by Acinetobacter baumannii : Are We Losing the Battle?
Protic, D. D., Pejović, A. T., Andjelkovic, D., Djukanović, N., Savic, D., Piperac, P., Denić, L. M., Zdravkovic, M. D., & Todorović, Z. (2016) · Surgical Infections · doi:10.1089/sur.2015.128 · Cited by 16
“Indeed, the incidence of nosocomial infections caused by Acinetobacter spp. is increasing constantly [5].”
Bahamondez-Canas, T., & Smyth, H. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2301-5 · Cited by 12
Blossom, D. B., & Srinivasan, A. (2008) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e3181635def · Cited by 16
Epidemiology of and Risk Factors for Acinetobacter Species Bloodstream Infection in Children
Segal, S. C., Zaoutis, T. E., Kagen, J., & Shah, S. S. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3180684310 · Cited by 16
“accounted for 5–10% of all Gram-negative BSIs.(34,35) Although no such national data exist in the pediatric literature, our findings suggest that Acinetobacter spp.”
BackgroundMoraski, G. C., Thanassi, J. A., Podos, S. D., Pucci, M. J., & Miller, M. J. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.67 · Cited by 16
DksA Modulates Antimicrobial Susceptibility of Acinetobacter baumannii
Kim, N., Son, J.-H., Kim, K., Kim, H., Shin, M., & Lee, J.-C. (2021) · Antibiotics · doi:10.3390/antibiotics10121472 · Cited by 15
Aedh, A. I., Al-Swedan, A. D., Mohammed, A. A., Alwadai, B. M., Alyami, A. Y., Alsaaed, E. A., Almurdhimah, N. M., Zaki, M. S., Othman, A. E., & Hasan, A. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8020108 · Cited by 15
“In selecting a preventive strategy, the prevalent bacterial isolates found in specific hospitals must be considered [5].”
BackgroundBai, X., Wang, Z.-Z., Li, W., Wang, Y.-G., Lou, R., Qu, X., Fan, L., Zhang, W., Wu, Y., Yan, S., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08815-7 · Cited by 15
“The incidence of pneumonia caused by Gram-negative organisms has significantly increased in the ICU [1].”
BackgroundHammami, S., Boubaker, I. B.-B., Saïdani, M., Lakhal, E., Hassen, A. B., Kamoun, A., Ghozzi, R., Slim, A., & Redjeb, S. B. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0074 · Cited by 15
Zheng, W., Yuan, S., & Li, L. (2013) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.11.004 · Cited by 15
Virtual Screening Approach of Bacterial Peptide Deformylase Inhibitors Results in New Antibiotics
Merzoug, A., Chikhi, A., Benseguenı, A., Boucherıt, H., & Okay, S. (2017) · Molecular Informatics · doi:10.1002/minf.201700087 · Cited by 15
Potensi +Dalethyne Terhadap Epitelisasi Luka pada Kulit Tikus yang Diinfeksi Bakteri MRSA
Sayogo, W. (2017) · Jurnal Biosains Pascasarjana · doi:10.20473/jbp.v19i1.2017.68-84 · Cited by 15
Karnik, T., Dempsey, S. G., Jerram, M. J., Nagarajan, A. P., Rajam, R., May, B. C. H., & Miller, C. H. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0155-0 · Cited by 15
Couchoud, C., Bertrand, X., Bourgeon, M., Piton, G., Valot, B., & Hocquet, D. (2022) · Journal of Hospital Infection · doi:10.1016/j.jhin.2023.01.010 · Cited by 17
Breidenstein, E. B. M., & Hancock, R. E. W. (2012) · Canadian Journal of Microbiology · doi:10.1139/cjm-2012-0681 · Cited by 15
Pseudomonas aeruginosa: A Persistent Pathogen in Cystic Fibrosis and Hospital-Associated Infections
Schurek, K. N., Breidenstein, E. B. M., & Hancock, R. E. W. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1400-1_21 · Cited by 26
NOSOCOMIAL INFECTIONS: AN OVERVIEW
Mohammed, M., Mohammed, A. H., Mirza, M. A. B., & Ghori, A. (2014) · International Research Journal of Pharmacy · doi:10.7897/2230-8407.050102 · Cited by 15
“pneumoniae and Acinetobacter species.(8)”
BackgroundInfluentialBaral, S., Pokharel, A., Subramanya, S. H., & Nayak, N. (2019) · Nepal Journal of Epidemiology · doi:10.3126/nje.v9i4.26962 · Cited by 15
Bacterial Surface Colonization of Sputter-Coated Platinum Films
Czerwińska-Główka, D., Przystaś, W., Zabłocka-Godlewska, E., Student, S., Cwalina, B., Łapkowski, M., & Krukiewicz, K. (2020) · Materials · doi:10.3390/ma13122674 · Cited by 15
Jokisalo, J., Bryan, J., Leggett, B., Abbott, Y., & Katz, L. M. (2010) · Equine Veterinary Education · doi:10.1111/j.2042-3292.2010.00071.x · Cited by 15
Jayaraman, S., Jiang, Y., Resch, S., Askari, R., & Klompas, M. (2016) · Surgical Infections · doi:10.1089/sur.2015.222 · Cited by 17
“Acinetobacter , a gram-negative bacterium, can increase the mortality rate by 22% in intensive care unit (ICU) patients and add $30,000 in patient charges for extra hospitalization [3–6].”
Appaneal, H. J., Caffrey, A. R., Jiang, L., Dosa, D. M., Mermel, L. A., & LaPlante, K. L. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.11.022 · Cited by 15
Eser, Ö. K., Ergin, A., Tunçkanat, F., & Hasçelik, G. (2008) · PubMed · Cited by 15
Reducing empirical use of fluoroquinolones for Pseudomonas aeruginosa infections improves outcome
Nguyen, L. H., Hsu, D. I., Ganapathy, V., Shriner, K. A., & Wong‐Beringer, A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm510 · Cited by 15
Moving Towards Real-Time Antimicrobial Management of Ventilator-Associated Pneumonia
Kollef, M. H. (2007) · Clinical Infectious Diseases · doi:10.1086/510595 · Cited by 15
The Dilemma of Multidrug-Resistant Gram-Negative Bacteria
Engel, L. S. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181e939c3 · Cited by 14
Altura, B. M., & Gebrewold, A. (2016) · Journal of Hematology & Thromboembolic Diseases · doi:10.4172/2329-8790.1000252 · Cited by 14
“Systemic bleeding seems to occur more with Ebola and Marburg viruses (Filo viruses), Crimean Congo Hemorrhagic Fever (Bunya virus), and the South American hemorrhagic fever virus (Arena viruses), compared to dengue and Yellow Fever (Flavi viruses), Rift Valley Fever (Bunya virus), and Lassa fever (Arena virus)[5-9].”
BackgroundInfluentialAntimicrobial strategies for polymeric hygienic surfaces in healthcare
Greenhalgh, R., & Walker, J. T. (2017) · International Biodeterioration & Biodegradation · doi:10.1016/j.ibiod.2017.09.009 · Cited by 16
Yamazaki, H., Yagi, A., Akaishi, M., Kirikoshi, R., Takahashi, O., Abe, T., Chiba, S., Takahashi, K., Iwakura, N., Namikoshi, M., et al. (2018) · Tetrahedron Letters · doi:10.1016/j.tetlet.2018.03.082 · Cited by 14
Tooker, B. C., Kandel, S. E., Work, H. M., & Lampe, J. N. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101629 · Cited by 16
“aeruginosa is a gram-negative 266 opportunistic pathogen that is particularly prevalent in the lungs of patients with cystic fibrosis, chronic 267 obstructive pulmonary disease, and nosocomial pneumonia (60-62).”
BackgroundPascale, R., Toschi, A., Aslan, A. T., Massaro, G., Maccaro, A., Fabbricatore, D., Dell’Aquila, A., Ripa, M., Işık, M. E., Kızmaz, Y. U., et al. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.106734 · Cited by 14
Antibiotic Resistance: A Guide for Effective Prescribing in Women's Health
Roe, V. A. (2008) · Journal of Midwifery & Women s Health · doi:10.1016/j.jmwh.2008.01.003 · Cited by 14
Enterobacter, Cronobacter, and Pantoea Species
Cunningham, D. J., & Leber, A. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00140-7 · Cited by 14
Cui, P., Wu, S., Xu, X., Ye, H., Hou, J., Liu, X., Wang, H., & Fang, X. (2018) · Shock · doi:10.1097/shk.0000000000001184 · Cited by 14
Korkerdsup, T., Ngarmukos, T., D, S. S. M., & Phuphuakrat, A. (2018) · Journal of Arrhythmia · doi:10.1002/joa3.12123 · Cited by 14
Profiling Antibiotic Resistance in Acinetobacter calcoaceticus
Glover, J. S., Ticer, T. D., & Engevik, M. A. (2022) · Antibiotics · doi:10.3390/antibiotics11070978 · Cited by 14
Beavers, S. F., Blossom, D. B., Wiemken, T. L., Kawaoka, K. Y., Wong, A. C., Goss, L., McCormick, M. I., Thoroughman, D. A., & Srinivasan, A. (2009) · Public Health Reports · doi:10.1177/003335490912400615 · Cited by 14
Evidence‐based algorithms for diagnosing and treating ventilator‐associated pneumonia
Wall, R. J., Ely, E. W., Talbot, T. R., Weinger, M. B., Williams, M. V., Reischel, J., Burgess, L. H., Englebright, J. D., Dittus, R. S., Speroff, T., et al. (2008) · Journal of Hospital Medicine · doi:10.1002/jhm.317 · Cited by 14
“Typical organisms include Staphylococcus aureus, Pseudomonas aeruginosa, Enterobacter species, Klebsiella pneumoniae, Acinetobacter species, Escherichia coli, and Haemophilus influenzae.(22,23) Unfortunately, the prevalence of antimicrobial resistance among VAP pathogens is increasing.”
BackgroundStella, N. A., Callaghan, J. D., Zhang, L. N., Brothers, K. M., Kowalski, R. P., Huang, J., Thibodeau, P. H., & Shanks, R. M. Q. (2017) · Research in Microbiology · doi:10.1016/j.resmic.2017.03.006 · Cited by 14
Clinical Predictors of Pseudomonas aeruginosa Bacteremia in Emergency Department
Choi, Y., Paik, J. H., Kim, J. H., Han, S. B., & Durey, A. (2018) · Emergency Medicine International · doi:10.1155/2018/7581036 · Cited by 14
“aeruginosa causes infections that usually occur late during hospital stay [12].”
BackgroundLiao, C., Sheng, W., Chen, Y., Hung, C., Wang, J., & Chang, S. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.01.015 · Cited by 14
Asensio, Á., Cantón, R., Vaqué, J., Calbo, F., Herruzo, R., Arribas, J. R., & Sáenz, M. ª. C. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)72691-0 · Cited by 14
“Bacteriemias Primarias De origen desconocido 38 (3) Asociada a dispositivo 42 (4) Secundarias 32 (3)”
BackgroundInfluentialAntimicrobial Use and Resistance Among Gram-negative Bacilli in an Italian Intensive Care Unit (ICU)
Bassetti, M., Cruciani, M., Righi, E., Rebesco, B., Fasce, R., Costa, A., Molinari, M. P., Mengoli, C., Pallavicini, F. B., & Viscoli, C. (2006) · Journal of Chemotherapy · doi:10.1179/joc.2006.18.3.261 · Cited by 14
Guidelines for the Prevention of Intravascular Catheter-Related Infections
(2002) · PsycEXTRA Dataset · doi:10.1037/e548442006-001 · Cited by 14
Lai, Y.-H., Mondal, S., Su, H.-T., Huang, S., Wu, M.-H., Huang, I., Lauderdale, T.-L. Y., Song, J., Shia, K., & Mong, K. T. (2021) · RSC Advances · doi:10.1039/d1ra01088c · Cited by 13
Akcan, N., Uyguner, Z. O., Baş, F., Altunoğlu, U., Toksoy, G., Karaman, B., Avcı, Ş., Abalı, Z. Y., Poyrazoğlu, Ş., Aghayev, A., et al. (2022) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2022.2021-9-19 · Cited by 14
Genetic Manipulation of Stenotrophomonas maltophilia
Welker, E. W., Domfeh, Y. E., Tyagi, D., Sinha, S., & Fisher, N. (2015) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc06f02s37 · Cited by 13
Balegar, K. K., Azeem, M. I., Spence, K., & Badawi, N. A. (2012) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.12023 · Cited by 13
Structure ofPseudomonas aeruginosainosine 5′-monophosphate dehydrogenase
Rao, V. A., Shepherd, S. M., Owen, R. P., & Hunter, W. N. (2013) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309113002352 · Cited by 13
Sharma, R., Rani, C., Mehra, R., Nargotra, A., Chib, R., Rajput, V. S., Kumar, S., Singh, S., Sharma, P. R., & Khan, I. A. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7123-y · Cited by 13
“Human infections owing to Gram-negative bacteria cause significant human health concerns (Weinstein et al. 2015).”
Lima, A. H., dos Santos, A. M., Alves, C. N., & Lameira, J. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12882 · Cited by 15
Rose, D. D., Pezzotti, P., Fontana, C., Altieri, A., Minelli, S., Mariotti, B., Cerretti, R., Leoni, D., Andreoni, M., & Sarmati, L. (2018) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2018.1492149 · Cited by 13
Gaber, S. N., Hemeda, E. E. M., Elsayeh, H.-A. S., Wahed, W. Y. A., Khalil, M. A. F., & Ibrahim, E. G. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.1.13 · Cited by 16
Risk factors and outcome of Pseudomonas aeruginosa bacteremia among adults visiting the ED
Lee, C., Lee, C.-H., & Hong, M. (2011) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2011.05.029 · Cited by 14
“Pseudomonas aeruginosa is a major nosocomial pathogen that can cause pneumonia, urinary tract infections, wound infections, and bacteremia [3].”
BackgroundPhillips, M. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00224-1 · Cited by 14
Gao, Y., Li, H., Yang, B., Wei, X., Zhang, C., Xu, Y., & Zheng, X. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-13779-9 · Cited by 13
[Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].
Bacakoğlu, F., Ekren, P. K., Taşbakan, M. S., Başarık, B., Pullukçu, H., Aydemir, Ş., Gürgün, A., & Başoğlu, Ö. K. (2009) · PubMed · Cited by 13
Paul, S., Biswas, S., Choudhuri, T., Bandyopadhyay, S., Mandal, S., & Bagdi, A. K. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00059 · Cited by 12
PLANT BASED QUORUM SENSING INHIBITORS OF PSEUDOMONAS AERUGINOSA
Gala, V., & Desai, K. B. (2014) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 12
The Cost of Responding to an Acinetobacter Outbreak in Critically Ill Surgical Patients
Jiang, Y., Resch, S., Liu, X., Rogers, S. O., Askari, R., Klompas, M., & Jayaraman, S. (2015) · Surgical Infections · doi:10.1089/sur.2015.036 · Cited by 13
“Acinetobacter baumannii , a gram-negative bacterium, is associated with approximately 2%–10% of all gram-negative bacterial infections in U.S. intensive care units (ICUs) and has a crude mortality rate as high as 52% [11,12].”
Tseng, C., Hsiao, P.-K., Chang, K.-C., Cheng, C.-C., Yiin, .-M., & Hsieh, C. (2014) · Indoor Air · doi:10.1111/ina.12165 · Cited by 12
Management of infections associated with neurocritical care
Rivera‐Lara, L., Ziai, W., & Nyquist, P. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63600-3.00020-9 · Cited by 12
Acinetobacter baumannii in Saudi Arabia: The New Growing Threat
Kharaba, A. M., Hussein, M. A., Al-Hameed, F. M., Mandourah, Y., Almekhlafi, G. A., Algethamy, H. M., Hamdan, A., Azem, M., Fatani, J., al Beshabshe, A., et al. (2019) · Saudi Critical Care Journal · doi:10.4103/2543-1854.259469 · Cited by 12
Shrestha, M., Bernhards, R. C., Fu, Y., Kaler, K. M. R., & Schubot, F. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-66555-z · Cited by 12
Shu, H., Li, L., Wang, Y., Guo, Y., Wang, C., Yang, C., Gu, L., & Cao, B. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s265195 · Cited by 12
Bacteria with a Potential for Multidrug Resistance in Hospital Material
de Souza, S. G. P., dos Santos, I. C., Bondezan, M. A. D., Corsatto, L. F. M., Caetano, I. C. D. S., Zaniolo, M. M., da Matta, R., Merlini, L. S., Barbosa, L. N., & Gonçalves, D. D. (2020) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0305 · Cited by 14
Bahrami, S., Shafiee, F., Hakamifard, A., Fazeli, H., & Soltani, R. (2021) · Iranian Journal of Microbiology · doi:10.18502/ijm.v13i1.5492 · Cited by 12
Clinical and Molecular Analyses of Recurrent Gram-Negative Bloodstream Infections
Bock, A., Hanson, B., Ruffin, F., Parsons, J. B., Park, L. P., Sharma‐Kuinkel, B. K., Mohnasky, M., Arias, C. A., Fowler, V. G., & Thaden, J. T. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac638 · Cited by 12
Hackbarth, C., & Hodges, R. S. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.01021.x · Cited by 12
“Pseudomonas aeruginosa is a ubiquitous opportunistic pathogen that has become one of the leading causes of hospital-acquired infections (1).”
Tackling antibiotic resistance in India
Wattal, C., & Goel, N. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.976612 · Cited by 14
DS86760016, a Leucyl-tRNA Synthetase Inhibitor with Activity against Pseudomonas aeruginosa
Kumar, M., Rao, M., Purnapatre, K. P., Barman, T. K., Joshi, V., Kashyap, A., Chaira, T., Bambal, R. B., Pandya, M., Khodor, S. A., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02122-18 · Cited by 13
Abioye, A. O., Sanyaolu, A. O., Dudzinska, P., Adepoju-Bello, A. A., & Coker, H. A. B. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666191021102256 · Cited by 12
Omics in urology: An overview on concepts, current status and future perspectives
Panunzio, A., Tafuri, A., Princiotta, A., Gentile, I., Mazzucato, G., Trabacchin, N., Antonelli, A., & Cerruto, M. A. (2021) · Urologia Journal · doi:10.1177/03915603211022960 · Cited by 13
Metadata
- Authors
- Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-15
- Volume
- 41
- Issue
- 6
- Pages
- 848-854
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2151958462
- Cited by
- 1,404
- References
- 26
- Citations by year
- 2026: 14 · 2025: 21 · 2024: 37 · 2023: 56 · 2022: 73 · 2021: 80 · 2020: 66 · 2019: 78 · 2018: 66 · 2017: 74 · 2016: 86 · 2015: 89 · 2014: 85 · 2013: 95 · 2012: 85
- FWCI
- 38.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- nosocomial infections, Gram-negative bacilli, intensive care unit, surgical site infection, urinary tract infection, bloodstream infection, Acinetobacter, antimicrobial resistance, epidemiological trends
- MeSH terms
- Cross Infection, Gram-Negative Bacteria, Humans, National Health Programs, Population Surveillance, Surgical Wound Infection, Time Factors, United States, Urinary Tract Infections, Gram-Negative Bacterial Infections, Pneumonia, Bacterial, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.